Literature DB >> 30179224

Ubiquitin-specific protease 7 sustains DNA damage response and promotes cervical carcinogenesis.

Dongxue Su1, Shuai Ma2, Lin Shan1, Yue Wang1, Yuejiao Wang2, Cheng Cao2, Beibei Liu1, Chao Yang1, Liyong Wang3, Shanshan Tian2, Xiang Ding4, Xinhua Liu2, Na Yu2, Nan Song2, Ling Liu2, Shangda Yang2, Qi Zhang2, Fuquan Yang4, Kai Zhang2, Lei Shi2.   

Abstract

Central to the recognition, signaling, and repair of DNA double-strand breaks (DSBs) are the MRE11-RAD50-NBS1 (MRN) complex and mediator of DNA damage checkpoint protein 1 (MDC1), the interplay of which is essential for initiation and amplification of the DNA damage response (DDR). The intrinsic rule governing the regulation of the function of this molecular machinery remains to be investigated. We report here that the ubiquitin-specific protease USP7 was physically associated with the MRN-MDC1 complex and that the MRN-MDC1 complex acted as a platform for USP7 to efficiently deubiquitinate and stabilize MDC1, thereby sustaining the DDR. Accordingly, depletion of USP7 impaired the engagement of the MRN-MDC1 complex and the consequent recruitment of the downstream factors p53-binding protein 1 (53BP1) and breast cancer protein 1 (BRCA1) at DNA lesions. Significantly, USP7 was overexpressed in cervical cancer, and the level of its expression positively correlated with that of MDC1 and worse survival rates for patients with cervical cancer. We demonstrate that USP7-mediated MDC1 stabilization promoted cervical cancer cell survival and conferred cellular resistance to genotoxic insults. Together, our study reveals a role for USP7 in regulating the function of the MRN-MDC1 complex and activity of the DDR, supporting the pursuit of USP7 as a potential therapeutic target for MDC1-proficient cancers.

Entities:  

Keywords:  Cancer; Cell Biology; DNA repair; Oncology; Ubiquitin-proteosome system

Mesh:

Substances:

Year:  2018        PMID: 30179224      PMCID: PMC6159995          DOI: 10.1172/JCI120518

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  83 in total

1.  MDC1 maintains genomic stability by participating in the amplification of ATM-dependent DNA damage signals.

Authors:  Zhenkun Lou; Katherine Minter-Dykhouse; Sonia Franco; Monica Gostissa; Melissa A Rivera; Arkady Celeste; John P Manis; Jan van Deursen; André Nussenzweig; Tanya T Paull; Frederick W Alt; Junjie Chen
Journal:  Mol Cell       Date:  2006-01-20       Impact factor: 17.970

2.  DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.

Authors:  Jirina Bartkova; Zuzana Horejsí; Karen Koed; Alwin Krämer; Frederic Tort; Karsten Zieger; Per Guldberg; Maxwell Sehested; Jahn M Nesland; Claudia Lukas; Torben Ørntoft; Jiri Lukas; Jiri Bartek
Journal:  Nature       Date:  2005-04-14       Impact factor: 49.962

Review 3.  Cancer susceptibility and the functions of BRCA1 and BRCA2.

Authors:  Ashok R Venkitaraman
Journal:  Cell       Date:  2002-01-25       Impact factor: 41.582

4.  The structural basis of modified nucleosome recognition by 53BP1.

Authors:  Marcus D Wilson; Samir Benlekbir; Amélie Fradet-Turcotte; Alana Sherker; Jean-Philippe Julien; Andrea McEwan; Sylvie M Noordermeer; Frank Sicheri; John L Rubinstein; Daniel Durocher
Journal:  Nature       Date:  2016-07-27       Impact factor: 49.962

5.  Histone H1 couples initiation and amplification of ubiquitin signalling after DNA damage.

Authors:  Tina Thorslund; Anita Ripplinger; Saskia Hoffmann; Thomas Wild; Michael Uckelmann; Bine Villumsen; Takeo Narita; Titia K Sixma; Chunaram Choudhary; Simon Bekker-Jensen; Niels Mailand
Journal:  Nature       Date:  2015-10-21       Impact factor: 49.962

Review 6.  DNA repair, genome stability and cancer: a historical perspective.

Authors:  Penny A Jeggo; Laurence H Pearl; Antony M Carr
Journal:  Nat Rev Cancer       Date:  2015-12-15       Impact factor: 60.716

Review 7.  Therapeutic opportunities within the DNA damage response.

Authors:  Laurence H Pearl; Amanda C Schierz; Simon E Ward; Bissan Al-Lazikani; Frances M G Pearl
Journal:  Nat Rev Cancer       Date:  2015-03       Impact factor: 60.716

8.  The role of ATM and 53BP1 as predictive markers in cervical cancer.

Authors:  Frank Roossink; Hylke W Wieringa; Maartje G Noordhuis; Klaske A ten Hoor; Mirjam Kok; Lorian Slagter-Menkema; Harry Hollema; Geertruida H de Bock; Elisabeth Pras; Elisabeth G E de Vries; Steven de Jong; Ate G J van der Zee; Ed Schuuring; G Bea A Wisman; Marcel A T M van Vugt
Journal:  Int J Cancer       Date:  2012-03-29       Impact factor: 7.396

9.  Mechanism of genomic instability in cells infected with the high-risk human papillomaviruses.

Authors:  Meelis Kadaja; Helen Isok-Paas; Triin Laos; Ene Ustav; Mart Ustav
Journal:  PLoS Pathog       Date:  2009-04-24       Impact factor: 6.823

10.  53BP1 is a reader of the DNA-damage-induced H2A Lys 15 ubiquitin mark.

Authors:  Amélie Fradet-Turcotte; Marella D Canny; Cristina Escribano-Díaz; Alexandre Orthwein; Charles C Y Leung; Hao Huang; Marie-Claude Landry; Julianne Kitevski-LeBlanc; Sylvie M Noordermeer; Frank Sicheri; Daniel Durocher
Journal:  Nature       Date:  2013-06-12       Impact factor: 49.962

View more
  31 in total

1.  USP9X-mediated deubiquitination of B-cell CLL/lymphoma 9 potentiates Wnt signaling and promotes breast carcinogenesis.

Authors:  Zesen Shang; Jiao Zhao; Qi Zhang; Cheng Cao; Shanshan Tian; Kai Zhang; Ling Liu; Lei Shi; Na Yu; Shangda Yang
Journal:  J Biol Chem       Date:  2019-05-09       Impact factor: 5.157

2.  USP7 targets XIAP for cancer progression: Establishment of a p53-independent therapeutic avenue for glioma.

Authors:  Gouranga Saha; Sibani Sarkar; Partha S Mohanta; Krishna Kumar; Saikat Chakrabarti; Malini Basu; Mrinal K Ghosh
Journal:  Oncogene       Date:  2022-10-15       Impact factor: 8.756

3.  Prognostic Value and Potential Role of Alternative mRNA Splicing Events in Cervical Cancer.

Authors:  Xiang-Yang Shao; Jin Dong; Han Zhang; Ying-Song Wu; Lei Zheng
Journal:  Front Genet       Date:  2020-07-10       Impact factor: 4.599

4.  Ubiquitin ligase CHIP regulates OTUD3 stability and suppresses tumour metastasis in lung cancer.

Authors:  Pengfei Zhang; Chaonan Li; Hongchang Li; Lin Yuan; Hongmiao Dai; Zhiqiang Peng; Zhikang Deng; Zhijie Chang; Chun-Ping Cui; Lingqiang Zhang
Journal:  Cell Death Differ       Date:  2020-06-01       Impact factor: 15.828

5.  CRISPR/Cas9 library screening uncovered methylated PKP2 as a critical driver of lung cancer radioresistance by stabilizing β-catenin.

Authors:  Chun Cheng; Xiaofeng Pei; Si-Wei Li; Jun Yang; Chenxi Li; Jianjun Tang; Kaishun Hu; Guofu Huang; Wei-Ping Min; Yi Sang
Journal:  Oncogene       Date:  2021-03-19       Impact factor: 9.867

Review 6.  Pro-apoptotic and anti-apoptotic regulation mediated by deubiquitinating enzymes.

Authors:  Hae-Seul Choi; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2022-02-03       Impact factor: 9.261

Review 7.  Involvement of E3 Ligases and Deubiquitinases in the Control of HIF-α Subunit Abundance.

Authors:  Kateryna Kubaichuk; Thomas Kietzmann
Journal:  Cells       Date:  2019-06-15       Impact factor: 6.600

Review 8.  SUMO-Targeted Ubiquitin Ligases and Their Functions in Maintaining Genome Stability.

Authors:  Ya-Chu Chang; Marissa K Oram; Anja-Katrin Bielinsky
Journal:  Int J Mol Sci       Date:  2021-05-20       Impact factor: 5.923

9.  A feedforward circuit shaped by ECT2 and USP7 contributes to breast carcinogenesis.

Authors:  Qi Zhang; Cheng Cao; Wenchen Gong; Kaiwen Bao; Qian Wang; Yuejiao Wang; Liyuan Bi; Shuai Ma; Jiao Zhao; Ling Liu; Shanshan Tian; Kai Zhang; Jie Yang; Zhi Yao; Nan Song; Lei Shi
Journal:  Theranostics       Date:  2020-08-29       Impact factor: 11.556

Review 10.  Targeting USP7-Mediated Deubiquitination of MDM2/MDMX-p53 Pathway for Cancer Therapy: Are We There Yet?

Authors:  Si-Min Qi; Gang Cheng; Xiang-Dong Cheng; Zhiyuan Xu; Beihua Xu; Wei-Dong Zhang; Jiang-Jiang Qin
Journal:  Front Cell Dev Biol       Date:  2020-04-02
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.